Journal of Pediatric Health Care
Volume 21, Issue 6 , Pages 392-395 , November 2007

Anticonvulsant Use for Prophylaxis of the Pediatric Migraine

  • Lea S. Eiland, PharmD, BCPS

      Affiliations

    • Lea S. Eiland is Associate Clinical Professor of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Huntsville, Ala.
    • Corresponding Author InformationCorrespondence: Lea S. Eiland, PharmD, BCPS, 301 Governors Dr, Huntsville, AL 35801

References 

  1. Belman A, Milazo M, Savatic M, Gabis L. Gabapentin for migraine prophylaxis in children. [Abstract] Annals of Neurology. 2001;50:S109
  2. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention. Journal of the American Medical Association. 2004;291:965–973
  3. Campistol J, Campos J, Casas C, Herranz J. Topiramate in the prophylactic treatment of migraine in children. Journal of Child Neurology. 2005;20:251–253
  4. Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000;40:672–676
  5. DeSouza TG, Shahid A, Waren SP. The use of levetiracetam in the prophylactic treatment of migraine headaches in adolescents. [Abstract] Headache. 2005;45:819–820
  6. Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: Pharmacological agents for prophylaxis. Annals of Pharmacotherapy. 2007;41:1181–1190
  7. Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S Depakote ER Migraine Study Group. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652–1659
  8. Hershey A, Powers S, Vockell A, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache. 2002;42:810–818
  9. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents (Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society). Neurology. 2004;63:2215–2224
  10. Miller G. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44:238–243
  11. Pakalnis A, Greenberg G, Drake ME, Paolichi J. Pediatric migraine prophylaxis with divalproex. Journal of Child Neurology. 2001;16:731–734
  12. Pakalnis A, Kring D. Zonisamide prophylaxis in refractory pediatric headache. Headache. 2006;46:804–807
  13. Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, et al. Sodium valproate prophylaxis in childhood migraine. Headache. 2002;42:819–822
  14. Shaygannedjad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valproate in migraine prevention: A randomized blinded crossover study. Headache. 2006;46:642–648
  15. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) (Report of the Quality Standards Subcommittee of the American Academy of Neurology). Neurology. 2000;55:754–762
  16. Silberstein S, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention. Archives of Neurology. 2004;61:490–495
  17. Vaisleib II, Neft RA, Schor NF. Role of levetiracetam in prophylaxis of migraine headaches in childhood. [Abstract] Neurology. 2005;64:A343
  18. Winner P, Pearlman E, Linder S, Jordan D, Fisher A, Hulihan J. Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial. Headache. 2005;45:1304–1312

PII: S0891-5245(07)00304-5

doi: 10.1016/j.pedhc.2007.08.006

Journal of Pediatric Health Care
Volume 21, Issue 6 , Pages 392-395 , November 2007

Article Tools